Choreo LLC lowered its position in shares of Arcosa, Inc. (NYSE:ACA – Free Report) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,034 shares of the company’s stock after selling 194 shares during the period. Choreo LLC’s holdings in Arcosa were worth $975,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC increased its stake in Arcosa by 80.9% during the 4th quarter. GAMMA Investing LLC now owns 331 shares of the company’s stock worth $32,000 after buying an additional 148 shares during the period. Point72 DIFC Ltd acquired a new stake in shares of Arcosa during the third quarter valued at about $37,000. Blue Trust Inc. increased its position in shares of Arcosa by 16.4% during the fourth quarter. Blue Trust Inc. now owns 1,240 shares of the company’s stock worth $118,000 after acquiring an additional 175 shares during the last quarter. KBC Group NV lifted its stake in shares of Arcosa by 20.5% in the third quarter. KBC Group NV now owns 1,424 shares of the company’s stock worth $135,000 after acquiring an additional 242 shares in the last quarter. Finally, First Trust Direct Indexing L.P. acquired a new position in shares of Arcosa in the third quarter worth about $206,000. 90.66% of the stock is owned by institutional investors and hedge funds.
Arcosa Stock Down 1.8 %
Shares of Arcosa stock opened at $101.71 on Monday. The company has a quick ratio of 2.77, a current ratio of 3.61 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $100.82 and a 200 day moving average price of $95.89. Arcosa, Inc. has a fifty-two week low of $72.75 and a fifty-two week high of $113.43. The firm has a market cap of $4.96 billion, a P/E ratio of 38.67 and a beta of 0.76.
Arcosa Dividend Announcement
Wall Street Analysts Forecast Growth
Several research firms have issued reports on ACA. Oppenheimer lifted their price objective on Arcosa from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Barclays began coverage on shares of Arcosa in a research note on Tuesday, October 29th. They issued an “overweight” rating and a $106.00 price target for the company.
Read Our Latest Research Report on Arcosa
About Arcosa
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
See Also
- Five stocks we like better than Arcosa
- Why Invest in High-Yield Dividend Stocks?
- 3 Volatility ETFs to Help You Profit from Market Chaos
- What is Forex and How Does it Work?
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Retail Stocks Investing, Explained
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.